Gryphon Financial Partners LLC Baxter International Inc Transaction History

Gryphon Financial Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$76.7 - $88.45 $168,816 - $194,678	-2,201 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$81.4 - $89.78 $179,161 - $197,605	2,201 New	2,201 $193,000
Q2 2019 Aug 09, 2019	SELL	$73.44 - $82.41 $790,214 - $886,731	-10,760 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$64.48 - $81.31 $52,551 - $66,267	815 Added 8.2%	10,760 $875,000
Q4 2018 Feb 11, 2019	BUY	$61.45 - $77.8 $611,120 - $773,721	9,945 New	9,945 $654,000
Q3 2018 Nov 06, 2018	SELL	$70.71 - $77.75 $129,611 - $142,515	-1,833 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $507 - $603	-8 Reduced 0.43%	1,833 $135,000
Q4 2017 Feb 09, 2018	BUY	$61.45 - $66.05 $113,129 - $121,598	1,841	1,841 $119,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gryphon Financial Partners LLC with notifications on news.